|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/439 | (2006.01) |
| A61K 39/39558 | (2013.01) | ||
| A61K 31/4545 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K 16/2827 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/439 | (2013.01) | ||
| A61K 31/4545 | (2013.01) |
| (11) | Number of the document | 3355902 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16779272.0 |
| Date of filing the European patent application | 2016-09-27 | |
| (97) | Date of publication of the European application | 2018-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/053939 |
| Date | 2016-09-27 |
| (87) | Number | WO 2017/058780 |
| Date | 2017-04-06 |
| (30) | Number | Date | Country code |
| 201562235406 P | 2015-09-30 | US | |
| 201662385430 P | 2016-09-09 | US | |
| 201662393609 P | 2016-09-12 | US |
| (72) |
LIN, Chia-Yang , US
PRIOR, Wei Wei Wu , US
QU, Yan , US
WANG, Changyu , US
|
| (73) |
Merck Patent GmbH ,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
Pfizer Inc. , 235 East 42nd Street, New York, NY 10017, US |
| (54) | COMBINATION OF A PD-1 AXIS BINDING ANTAGONIST AND AN ALK INHIBITOR FOR TREATING ALK-NEGATIVE CANCER |
| COMBINATION OF A PD-1 AXIS BINDING ANTAGONIST AND AN ALK INHIBITOR FOR TREATING ALK-NEGATIVE CANCER |